10202017Headline:

Los Angeles, California

HomeCaliforniaLos Angeles

Email Paul Kiesel Paul Kiesel on LinkedIn Paul Kiesel on Twitter Paul Kiesel on Facebook
Paul Kiesel
Paul Kiesel
Contributor •

Digitek Digoxin Recall

Comments Off

On April 28, 2008 the Food and Drug Administration (FDA) issued a recall on all Digitek (digoxin) tablets, which may contain twice the approved level of digoxin.  The existence of double-strength pills pose a risk of digitalis toxicity, which can result in nausea, vomiting, low blood pressure, cardiac instability, bradycardia and even death.  KBL is currently investigating the death of a Southern California heart patient who was taking one of the recalled lots distributed by Mylan Pharmaceuticals, Inc.  The recalled digoxin tablets, Digitek, is a registered trademark of Actavis Totowa (formerly Amide Pharmaceutical, Inc.